Search results
Results from the WOW.Com Content Network
Abbott Laboratories is also an excellent dividend stock, currently on a streak of 52 consecutive payout increases. If you opt to reinvest the dividend -- currently yielding 1.8% -- you'll see ...
Like Abbott, this too is a dividend growth stock with an impressive streak. ... Its payout ratio is 64%, making the dividend very manageable for the company to maintain while also making it ...
Abbott should also maintain its dividend, which yields about 2.1%. The company has been increasing payouts for 52 consecutive years. Thus, the stock is a strong pick for long-term dividend investors.
The company has been paying a dividend since 1924, and like Coca-Cola, it is a Dividend King. Abbott's strong diversification and modest payout ratio of 66% make it highly probable that there will ...
And since it split from Abbott in 2013, AbbVie has increased its dividend by 310%. The stock's forward yield is now around 3.8%, compared to the S&P 500's average of 1.3%. So despite its recent ...
Abbott has increased its quarterly dividend payout by 60% since 2020 -- and the company's track record of boosting its dividend for more than 50 years suggests rewarding shareholders remains a ...
The stock has a dividend yield of 2.2%, and with a payout ratio of only 25%, the company's financial situation looks strong. The Federal Reserve's stress tests show that banks are in a sound ...
A secretary bought three shares of her company's stock for $60 each in 1935. Grace Groner reinvested her dividends for 75 years, and her stake ballooned to $7.2 million. Her employer, Abbott ...